Home
This site is intended for healthcare professionals
Advertisement

Preclinical Cardiology Tutorial - Ischaemia

Share
Advertisement
Advertisement
 
 
 

Summary

Join our on-demand teaching session, "IschaemiaThe Case," part of our Cardiology Teaching Series intended for medical professionals. This session examines a case study involving Mr P, a 56-year-old man with cardiac symptoms. The session delivers a comprehensive understanding of atherosclerosis, risk factors for heart disease, and the sequence leading to a heart attack. Additionally, the session explores diagnostic techniques, including ECG reading, pharmacology related to cardiac emergencies, the importance and strategies of immediate intervention, and secondary preventative measures. By attending this session, you will also participate in Self-Assessment Questions to test your knowledge on MI lab findings, coronary vasodilation, ACE inhibitor usage, and myocardial infarction indicators. This session will equip you with detailed insights and practical knowledge, enhancing your efficiency in diagnosing and handling cardiology cases.

Generated by MedBot

Description

Next in our series of Preclinical Cardiology events is a tutorial outlining myocardial ischaemia. By the end of this tutorial, participants will be able to describe the pathophysiology of atherosclerosis, plaque rupture and thrombosis as well as how this can manifest in common cardiovascular events.

Providing a concise summary of the physiology and pharmacology surrounding high-yield core conditions, attending this webinar is an ideal way of beginning to bridge preclinical concepts with clinical scenarios.

This tutorial will be interactive, with plenty of opportunity to ask questions and answer SBAs!

When: 18:00 Tuesday 18th February 2025

Where: Online via MedAll

Learning objectives

  1. To identify and understand the risk factors for heart disease, focusing on the specific case of Mr. P.
  2. To comprehend the pathophysiology of atherosclerosis and how it leads to myocardial infarction.
  3. To recognize the symptoms and signs of ischaemia and learn how to analyze ECG for indications of myocardial infarction.
  4. To become familiar with the pharmacological interventions for myocardial ischaemia and their mechanism of action.
  5. To be able to assess and interpret key laboratory findings following myocardial infarction.
Generated by MedBot

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Cardiology Teaching Series Session 3 - IschaemiaThe Case Mr P is a 56-year-old man, who is brought into hospital by ambulance. He describes being out on a walk when he noticed a crushing chest pain, as well as pain in his left arm. He remarks feeling quite sweaty at the time as well. Mr P smokes daily, and sees his GP regularly to manage his high blood pressure. What is the likely diagnosis here?Starting from the basics + Tunica adventitia – tough structural layer composed of connective tissue + Tunica media – maintains tone and composed of smooth muscle and elastic fibres + Tunica intima – Endothelial layer, acts as a protective barrier https://training.seer.cancer.gov/anatomy/cardiovascular/blood/classification.htmlPathophysiology of atherosclerosis DOI:10.1042/BSR20212355Back to The Case Mr P is a 56-year-old man, who is brought into hospital by ambulance. He describes being out on a walk when he noticed a crushing chest pain, as well as pain in his left arm. He remarks feeling quite sweaty at the time as well. Mr P smokes daily, and sees his GP regularly to manage his high blood pressure and type 2 diabetes mellitus. What risk factors does Mr P have for heart disease?Risk factors for endothelial activation + Diabetes - Advanced glycation end products + Oxidative stress – smoking + Obesity - inflammatory cytokines + Hypertension + Hypercholesterolaemia + Etc.So why the sudden heart attack? + Unstable plaque → rupture + Exposure of the thrombogenic lipid core + Platelet activation → release thromboxane A2 (TXA2) and ADP + ADP binds to P2Y12 receptors → cross-linking → platelet plug + Conversion of fibrinogen → fibrin,forming a mesh over the plug + This occludes the artery → hypoxia to cardiomyocytes (ischaemia) → death (infarction) + What results might you see in a blood test?Back to The Case Mr P’s ECG is shown below:Localising MIsPharmacology + Unstable plaque → rupture + Exposure of the thrombogenic lipid core ASPIRIN + Platelet activation → release thromboxane A2 (TXA2) and ADP + ADP binds to P2Y12 receptors → cross-linking → platelet plug CLOPIDOGREL + Conversion of fibrinogen → fibrin,forming a mesh over the plug ALTEPLASE + This occludes the artery → hypoxia to cardiomyocytes (ischaemia) → death (infarction)Intervention + Early reperfusion is key: Thrombolysis – Alteplase Percutaneous Coronary Intervention + Secondary prevention: Statin – HMG-CoA reductase inhibitor Aspirin and Clopidogrel ACEi Beta blockerSBA 1 + Which of the following lab findings is most specific for MI? A) Raised CK-MB B) Raised troponin C) Raised myoglobin D) Raised D-Dimer E) Raised ESRSBA 1 + Which of the following lab findings is most specific for MI? A) Raised CK-MB B) Raised troponin C) Raised myoglobin D) Raised D-Dimer E) Raised ESRSBA 2 + Which of the following normally plays the most important role in regulating coronary vasodilation? A) Sympathetic activation B) Endothelin-1 release C) Myogenic reflex D) Nitric oxide release E) Inhibition of the Na-K ATPase pumpSBA 2 + Which of the following normally plays the most important role in regulating coronary vasodilation? A) Sympathetic activation B) Endothelin-1 release C) Myogenic reflex D) Nitric oxide release E) Inhibition of the Na-K ATPase pumpSBA 3 + Why are patients started on ACE inhibitors following a myocardial infarction? A) Increases blood pressure and coronary perfusion B) Reduces platelet aggregation and clot formation C) Prevents adverse ventricular remodelling D) Blocks sympathetic overactivity E) Reduces LDLlevels in the bloodSBA 3 + Why are patients started on ACE inhibitors following a myocardial infarction? A) Increases blood pressure and coronary perfusion B) Reduces platelet aggregation and clot formation C) Prevents adverse ventricular remodelling D) Blocks sympathetic overactivity E) Reduces LDLlevels in the bloodSBA 4 + Why does ST elevation occur in myocardial infarction? A) Increased ventricular depolarisation B) Failure of repolarisation due to ischaemic injury C) Increased sympathetic activity D) Decreased calcium influx into myocytes E) Increased cardiac outputSBA 4 + Why does ST elevation occur in myocardial infarction? A) Increased ventricular depolarisation B) Failure of repolarisation due to ischaemic injury C) Increased sympathetic activity D) Decreased calcium influx into myocytes E) Increased cardiac output